To generate cost savings, plan sponsors should implement transitional care programs and disease management programs that consider risk, actionability, treatment and program effectiveness, and costs.
Brenda R. Motheral, PhD
Advertisement
Articles by Brenda R. Motheral, PhD
To generate cost savings, plan sponsors should implement transitional care programs and disease management programs that consider risk, actionability, treatment and program effectiveness, and costs.
Advertisement
Latest Updated Articles
- Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy
Published: July 1st 2004 | Updated:
- Clinical and Financial Outcomes Associated With a Proton Pump Inhibitor Prior-Authorization Program in a Medicaid Population
Published: January 15th 2005 | Updated:
- Telephone-Based Disease Management: Why It Does Not Save Money
Published: March 10th 2011 | Updated:
- Telephone-Based Disease Management: Why It Does Not Save Money
Published: January 14th 2011 | Updated:
- The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation
Published: November 1st 1999 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
How Clinician-Led Partnerships Strengthen Post-Acute Care
4
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
5
